These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Survival analysis with time-dependent covariates subject to missing data or measurement error: Multiple Imputation for Joint Modeling (MIJM). Moreno-Betancur M; Carlin JB; Brilleman SL; Tanamas SK; Peeters A; Wolfe R Biostatistics; 2018 Oct; 19(4):479-496. PubMed ID: 29040396 [TBL] [Abstract][Full Text] [Related]
6. General concepts in biostatistics and clinical epidemiology: Observational studies with cross-sectional and ecological designs. Cataldo R; Arancibia M; Stojanova J; Papuzinski C Medwave; 2019 Sep; 19(8):e7698. PubMed ID: 31596838 [TBL] [Abstract][Full Text] [Related]
7. The misuse and abuse of statistics in biomedical research. Thiese MS; Arnold ZC; Walker SD Biochem Med (Zagreb); 2015; 25(1):5-11. PubMed ID: 25672462 [TBL] [Abstract][Full Text] [Related]
8. Erratum to: Letter to the Editor: The ongoing tyranny of statistical significance testing in biomedical research. VanderWeele TJ Eur J Epidemiol; 2010 Dec; 25(12):899-900. PubMed ID: 21190126 [No Abstract] [Full Text] [Related]
9. Understanding the effect size and its measures. Ialongo C Biochem Med (Zagreb); 2016; 26(2):150-63. PubMed ID: 27346958 [TBL] [Abstract][Full Text] [Related]
12. Response to letter by Frane: "False discovery rate control is not always a replacement for Bonferroni-type adjustment". Glickman ME; Rao SR; Schultz MR J Clin Epidemiol; 2016 Jan; 69():264. PubMed ID: 26139437 [No Abstract] [Full Text] [Related]
13. False discovery rate control is not always a replacement for Bonferroni adjustment (Letter commenting on: J Clin Epidemiol. 2014;67:850-7). Frane AV J Clin Epidemiol; 2016 Jan; 69():263. PubMed ID: 26130494 [No Abstract] [Full Text] [Related]
14. Sequential Monte Carlo for response adaptive randomized trials. Golchi S; Thorlund K Biostatistics; 2020 Apr; 21(2):287-301. PubMed ID: 30202898 [TBL] [Abstract][Full Text] [Related]
15. Resolution of Students t-tests, ANOVA and analysis of variance components from intermediary data. Anders K Biochem Med (Zagreb); 2017 Jun; 27(2):253-258. PubMed ID: 28740445 [TBL] [Abstract][Full Text] [Related]
16. Modern statistical modeling approaches for analyzing repeated-measures data. Hayat MJ; Hedlin H Nurs Res; 2012; 61(3):188-94. PubMed ID: 22551993 [TBL] [Abstract][Full Text] [Related]
17. Sample size estimation for repeated measures analysis in randomized clinical trials with missing data. Lu K; Luo X; Chen PY Int J Biostat; 2008; 4(1):Article 9. PubMed ID: 22462117 [TBL] [Abstract][Full Text] [Related]
18. Repeated Measures Designs and Analysis of Longitudinal Data: If at First You Do Not Succeed-Try, Try Again. Schober P; Vetter TR Anesth Analg; 2018 Aug; 127(2):569-575. PubMed ID: 29905618 [TBL] [Abstract][Full Text] [Related]
19. Using multivariate mixed-effects selection models for analyzing batch-processed proteomics data with non-ignorable missingness. Wang J; Wang P; Hedeker D; Chen LS Biostatistics; 2019 Oct; 20(4):648-665. PubMed ID: 29939200 [TBL] [Abstract][Full Text] [Related]
20. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Bellan SE; Pulliam JR; Pearson CA; Champredon D; Fox SJ; Skrip L; Galvani AP; Gambhir M; Lopman BA; Porco TC; Meyers LA; Dushoff J Lancet Infect Dis; 2015 Jun; 15(6):703-10. PubMed ID: 25886798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]